Back to Search
Start Over
Commentary: Shall we wait for two days more? Can we take this risk?
- Publication Year :
- 2022
- Publisher :
- Elsevier Inc., 2022.
- Subjects :
- Pulmonary and Respiratory Medicine
recurrent disease
MEDLINE
reoperation
ticagrelor
acute coronary syndrome
Medicine
human
transfusion
clopidogrel
business.industry
practice guideline
percutaneous coronary intervention
acetylsalicylic acid
medicine.disease
bleeding
purinergic P2Y12 receptor
dual antiplatelet therapy
prasugrel
acute heart infarction
hospital admission
Editorial
Waiting List
incidence
Surgery
Medical emergency
cerebrovascular accident
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....30b515127f752e8b029edcccd7d05d50